Skip to content
Home/Companies/Technology/Isto Biologics

Isto Biologics

Technology·US·Active·1yr hold
Entry
2025
Hold
1yr
Status
Active

Who owns Isto Biologics?

Isto Biologics is currently owned by Keensight Capital through Keensight Nova VI (2023 vintage), since 2025.

Hand-verified · updated 2026-04-21

Keensight Capital
Investor
Keensight Capital
Keensight Nova VI · 2023 · Buyout

Key facts

HQUnited States
SectorTechnology

More from Keensight Nova VI

Other portfolio companies in the same fund.

ACTICO Group
ACTICO Group
Active
AI/MLGermany· 2025
Decision Focus
Active
TMTUK· 2025
Aprovall
Aprovall
Active
TMTFrance· 2024
E-Attestation
Active
SaaSFrance· 2023
Geomedia
Active
IT ServicesFrance· 2023
Nomios Group
Nomios Group
Active
TMTFrance· 2023

More PE-backed in TMT

Comparable tmt deals from other GPs.

3Bee
3Bee
Active
AgFunderUS
A+ Network
Active
Summit PartnersUS
A10 Networks
A10 Networks
Active
Summit PartnersUS
ABAX
ABAX
Active
InvestcorpNorway
ABC Fitness Solutions
ABC Fitness Solutions
Active
Thoma BravoUS
Ablynx
Exited 2013
GimvBelgium
Track Isto Biologics

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on Isto Biologics.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue